STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

BALTIMORE--(BUSINESS WIRE)-- Medifast (NYSE: MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended September 30, 2025 on Monday, November 3, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

The conference call is scheduled to begin at 4:30 p.m. ET on November 3, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1737984&tp_key=fe2490eae4 and will be archived online and available through February 3, 2026. To join via telephone, listeners may dial (201) 389-0879.

A telephonic playback will be available from 8:30 p.m. ET, November 3, 2025, through November 10, 2025. Participants can dial (412) 317-6671 and enter access code 13756407 to hear the playback.

About Medifast®:

Medifast (NYSE: MED) is the health and wellness company offering a simple, yet comprehensive approach to weight management and lifestyle change through its science-backed and coach-guided lifestyle system. Designed to address the challenges of metabolic dysfunction, the company’s lifestyle system integrates personalized plans, scientifically developed products and a framework for habit creation — all supported by a unique network of independent coaches. Science is core to the company, marked by an in-house Scientific & Clinical Affairs team and independent esteemed Scientific Advisory Board, 30+ research studies, 70+ scientific abstract presentations and publications, and 30+ publications in peer-reviewed scientific journals. With more than 40 years of clinical heritage, Medifast is addressing the metabolic health crisis through cutting-edge science and community-driven support and remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature®. For more information visit MedifastInc.com and follow Medifast on X and LinkedIn.

MED-F

Investor Contact:

Medifast, Inc.

Steven Zenker

InvestorRelations@medifastinc.com

(443) 379-5256

Source: Medifast

Medifast

NYSE:MED

MED Rankings

MED Latest News

MED Latest SEC Filings

MED Stock Data

119.59M
10.63M
3.2%
80.11%
18.8%
Personal Services
Miscellaneous Food Preparations & Kindred Products
Link
United States
BALTIMORE